BICO Group AB has the GF Score of 65, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes BICO Group AB
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
BICO Group AB (HAM:49Z) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
BICO Group AB GF Score Related Terms
HAM:49Z vs ABT, SYK, MDT: GF Score Comparison
For the Medical Devices subindustry, BICO Group AB's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BICO Group AB GF Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's GF Score distribution charts can be found below:
* The bar in red indicates where BICO Group AB's GF Score falls into.
BICO Group AB (HAM:49Z) has a GF Score of 65 as of Jul. 08, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on BICO Group AB and its competitors. This is near median its historical median of 65.00. Over the past decade, BICO Group AB's GF Score has ranged from 53.00 to 70.00.
Is BICO Group AB's GF Score too high?
BICO Group AB's current GF Score of 65 is near median its 10-year median of 65.00. Over the past 10 years, this metric has ranged from a low of 53.00 to a high of 70.00. Overall, BICO Group AB has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's GF Score compare to ABT and SYK?
BICO Group AB's GF Score of 65 can be compared against companies in the Medical Devices & Instruments industry. Historically, BICO Group AB's own GF Score has ranged from 53.00 to 70.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Medical Devices & Instruments company?
A good GF Score depends on the Medical Devices & Instruments industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on BICO Group AB and its competitors. BICO Group AB's current GF Score is 65, which is near median its own 10-year median of 65.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
BICO Group AB (HAM:49Z) has a current GF Score of 65. The stock's GF Value™ is €2.81, compared to a current price of €1.22 — trading 56.7% below its estimated fair value. The current GF Score is 65, which is near median its 10-year median of 65.00. BICO Group AB's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For BICO Group AB (HAM:49Z), the current GF Score is 65 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BICO Group AB (HAM:49Z) Overvalued in 2026?
Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued.
The current stock price of €1.22 is trading 56.7% below its estimated GF Value™ of €2.81.
Key valuation signals for HAM:49Z:
GF Score: 65 (near median its 10-year median of 65.00)
GF Value™: €2.81 vs. price of €1.22 (56.7% below fair value)
No single metric tells the full story. See the HAM:49Z stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
65GF Score
Get the complete analysis for HAM:49Z
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:49Z has been successfully added to your 